Dr. Jérôme Bouaziz is a distinguished specialist in gynecology-obstetrics and reproductive medicine, renowned for his innovative contributions to healthcare in France. As the CEO and Founder of One Clinic and PointGyn, he spearheads a transformative healthcare organization comprising over 500 physicians and operating more than 35 facilities nationwide.
Dr. Bouaziz is dedicated to redefining healthcare delivery through a holistic and integrative approach. Under his leadership, One Clinic specializes in various services, including in vitro fertilization (IVF), robotic surgery, teleophthalmology with mobile units, and regular consultations. These services are designed to prioritize individual patient needs and outcomes.
With a commitment to integrating best medical practices with cutting-edge digital health solutions, Dr. Bouaziz enhances preventive care and streamlines patient experiences. One Clinic adopts a Value-Based Health Care (VBHC) framework, advocating for patient-centric strategies that align with modern healthcare demands.
His multidisciplinary teams collaborate across diverse medical fields to ensure personalized care in a supportive environment, fostering strong connections between community and hospital care. Through his vision and leadership, Dr. Bouaziz is reshaping the healthcare landscape in France, improving accessibility and responsiveness for patients.
From Reactive to Proactive: Leveraging AI for Comprehensive Preventive Strategies in Women's Healthcare
Background: Preventive care is crucial for enhancing women's health outcomes, yet its implementation often encounters significant barriers in clinical practice. At One Clinic, a pioneer in integrative medicine in France, we have developed a practical, AI-assisted preventive care model designed to provide a holistic overview of women's health. This approach empowers physicians to adopt a 360-degree vision of their patients’ health by addressing a wide spectrum of gynecological concerns, including oncology, contraception, cardiovascular risk assessment, mental health, sexual health, menopause, and social factors.
Methods: We introduced an intelligent online questionnaire that patients complete before their consultations. This innovative tool assesses risk factors and generates personalized recommendations tailored to each patient’s needs. Results are tagged to facilitate the clinic's organization of additional examinations as required. The study involved 1,570 patients and 45 gynecologists, ensuring the relevance of AI-generated recommendations through physician validation.
Results: Our model successfully identified preventive care opportunities in 78% of patients, with 56% of the recommendations extending beyond the physicians' initial consultation scope. Notably, in 38% of cases, patients were able to undergo additional risk factor screenings on the same day, including blood tests, ultrasounds, mammograms, osteodensitometry, MRIs, and consultations with endocrinologists, cardiologists, or psychologists. Patient satisfaction was significantly elevated, with 82% preferring this comprehensive, proactive care model. Specific case studies illustrated the effectiveness of early interventions in addressing critical health issues.
Conclusion: The integration of AI in preventive care is not just beneficial but essential for advancing women’s health. This practical tool fosters a systematic approach to health prevention, ensuring thorough patient management while overcoming the barriers typically faced by healthcare professionals. Our findings advocate for the widespread adoption of AI-assisted preventive strategies across healthcare settings, reinforcing the importance of proactive care in women's health.